The average weekly consumption recorded during the pre-treatment, treatment and post-treatment periods, within the 0.005% and 0.01% warfarin-treated plots and the control plot.</p
Observed average monthly HTS and VMMC rates by study condition, over entire study period and within ...
Warfarin has been in clinical use for nearly 60 years, andin 2010 there were 25 million prescription...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
The international normalized ratio (INR) should be measured monthly once therapeutic levels are achi...
The aim of this study was to investigate the relationship between warfarin dosage, international nor...
Aim. To compare two approaches to warfarin dosage formulation: the standard and with the clinical al...
Aim. To develop a questionnaire to assess the individual risk of food interactions in a patient taki...
OBJECTIVE: The purpose of this study was to analyze the difference in duration of anticoagulation an...
In many clinical conditions, warfarin (WAR) is an essential and not replaceable drug that requires a...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the horizontal li...
The clinical effectiveness of warfarin as an anticoagulant in the primary and secondary prevention a...
Background: Anticoagulation control is a strong predictor of Iclinical outcomes for patients on warf...
<p>Mean and median warfarin dose increased as WRI increased. WR 0, WRI 1 and WRI 2 classes are as sp...
Objective: to evaluate the influence of structurized dosing of warfarin in patients with permanent a...
The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...
Observed average monthly HTS and VMMC rates by study condition, over entire study period and within ...
Warfarin has been in clinical use for nearly 60 years, andin 2010 there were 25 million prescription...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...
The international normalized ratio (INR) should be measured monthly once therapeutic levels are achi...
The aim of this study was to investigate the relationship between warfarin dosage, international nor...
Aim. To compare two approaches to warfarin dosage formulation: the standard and with the clinical al...
Aim. To develop a questionnaire to assess the individual risk of food interactions in a patient taki...
OBJECTIVE: The purpose of this study was to analyze the difference in duration of anticoagulation an...
In many clinical conditions, warfarin (WAR) is an essential and not replaceable drug that requires a...
<p>Each box indicates the values from 25° to 75° percentile (interquartile range), the horizontal li...
The clinical effectiveness of warfarin as an anticoagulant in the primary and secondary prevention a...
Background: Anticoagulation control is a strong predictor of Iclinical outcomes for patients on warf...
<p>Mean and median warfarin dose increased as WRI increased. WR 0, WRI 1 and WRI 2 classes are as sp...
Objective: to evaluate the influence of structurized dosing of warfarin in patients with permanent a...
The rate of prothrombin time measurements during the warfarin therapy in patients with incident NVAF...
Observed average monthly HTS and VMMC rates by study condition, over entire study period and within ...
Warfarin has been in clinical use for nearly 60 years, andin 2010 there were 25 million prescription...
Background: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism a...